Clear Perspective Advisors’s Avanos Medical AVNS Stock Holding History

Clear Perspective Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8	Closed	–	–	414
2016 Q4	$0	Buy	+8	New	+$286	﹤0.01%	413

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clear Perspective Advisors's AVNS Position: Q1 2017 in Review

Clear Perspective Advisors sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 8 shares.

Clear Perspective Advisors first reported a position in AVNS in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

Clear Perspective Advisors reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
Clear Perspective Advisors sold 8 Avanos Medical shares in Q1 2017.
Clear Perspective Advisors first reported a position in Avanos Medical in Q4 2016 and held it in 1 quarter.
Clear Perspective Advisors's Avanos Medical position peaked at $0 in Q4 2016.
335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on Clear Perspective Advisors's 13F filing for Q1 2017, filed 15 May 2017.